These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12822607)

  • 1. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
    Hanagiri T; Sugio K; Mizukami M; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Yasumoto K
    J Thorac Oncol; 2008 Oct; 3(10):1127-32. PubMed ID: 18827608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
    Martini N; Rusch VW; Bains MS; Kris MG; Downey RJ; Flehinger BJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):32-6; discussion 37-8. PubMed ID: 9869756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma.
    Yoshino I; Kawano D; Oba T; Yamazaki K; Kometani T; Maehara Y
    Ann Thorac Surg; 2006 Apr; 81(4):1189-93. PubMed ID: 16564239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma.
    Shiba M; Kohno H; Kakizawa K; Iizasa T; Otsuji M; Saitoh Y; Hiroshima K; Ohwada H; Fujisawa T
    Cancer; 2000 Oct; 89(7):1457-65. PubMed ID: 11013358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for young patients with lung cancer.
    Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
    Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
    Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients.
    Shiba M; Kakizawa K; Kohno H; Shibuya K; Yamakawa H; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2001 Jun; 71(6):1765-71. PubMed ID: 11426745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
    Nakamura H; Hirata T; Kitamura H; Nishikawa J
    Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
    Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
    Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.